BioMed Research International / 2018 / Article / Fig 1

Research Article

LincRNA-p21 Inhibits Cell Viability and Promotes Cell Apoptosis in Parkinson’s Disease through Activating -Synuclein Expression

Figure 1

The expression levels of lincRNA-p21 was detected in PD model mice and cells, and effects of lincRNA-p21 on cell viability and apoptosis of PD cells were shown. (a, b) The expression levels of lincRNA-p21 were increased significantly in PD mice and MPP+-induced SH-SY5Y cells. (c) Knockdown or overexpression of lincRNA-p21 increased or suppressed cell viability obviously in SH-SY5Y cells treated with MPP+. (d) Knockdown or overexpression of lincRNA-p21 inhibited or increased the activity of caspase-3 (cell apoptosis) markedly in SH-SY5Y cells treated with MPP+. All data are shown as the mean ± SD (P < 0.01, P < 0.001); bar, SD.
(a)
(b)
(c)
(d)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.